Shared care guidelines
Loading…
Please refer to the introduction for an overview of shared care and shared care guidelines and to find the relevant templates and request forms.
April 2022 - APC Approved list of guideline review date extensions (to 3 years from date approved)
-
Epilepsy - Antiepileptics in Adults
Brain and mental health
-
Fidaxomicin Amber G Guideline
Laboratory investigations and Infections
-
Finerenone in patients with CKD and type 2 diabetes
Endocrine and Diabetes
-
Freestyle Libre - Protocol for Adults (APC Approved)
Endocrine and Diabetes
-
Freestyle Libre - Protocol for Children (APC Approved)
Endocrine and Diabetes
-
Ganciclovir 0.15% eye gel
Ophthalmology and ENT
-
Gender Dysphoria (1)
Endocrine and Diabetes
-
GLP1 Agonist (APC Approved)
Endocrine and Diabetes
This guidance has been produced following an AMBER-G classification status of liraglutide, lixisenatide, dulaglutide and semaglutide by the Barnsley Area Prescribing Committee. This guideline was ratified by the Area Prescribing Committee on 12th February 2020.
-
Goserelin (Zoladex) for Breast Cancer
Cancer, Palliative Care, Pain and Older People
Women's and Sexual Health
-
Growth Hormone (Somatropin)
Endocrine and Diabetes
Did you find this page helpful?